Aclarion, Inc.
ACON • NASDAQ
Aclarion, Inc. is a medical - healthcare information services company in the healthcare sector trading on NASDAQ, led by CEO Brent Ness, with a market cap of $2.5M.
CEOBrent Ness
Market Cap$2.5M
Medical - Healthcare Information Services
Healthcare
Employees6.0
Websiteaclarion.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Aclarion, Inc.
Date
Wednesday, April 8, 2026 (in 2 months)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q4 2025
EPS Estimate
-$3.60
Revenue Estimate
$20.0K
Earnings History
Past 12 earnings reports for Aclarion, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 12, 2025 | Q3 2025 | -$2.93Est: -$2.64 | -11.0% | $18.9KEst: $20.0K | -5.3% |  10-Q |
| Aug 14, 2025 | Q2 2025 | -$2.75Est: -$2.26 | -21.7% | $19.3KEst: $30.0K | -35.6% | 10-Q |
| May 15, 2025 | Q1 2025 | -$9.32Est: -$1,447.19 | +99.4% | $19.0KEst: $25.0K | -24.0% | 10-Q |
| Apr 9, 2025 | Q4 2024 | -$986.50Est: -$1,356.74 | +27.3% | $10.2KEst: $17.5K | -41.5% | 10-K |
| Nov 14, 2024 | Q3 2024 | -$1,498.50Est: -$1,698.30 | +11.8% | $14.4KEst: $20.0K | -28.0% | 10-Q |
| Aug 14, 2024 | Q2 2024 | -$1,498.50Est: -$1,898.10 | +21.1% | $11.0KEst: $20.0K | -45.1% | 10-Q |
| May 15, 2024 | Q1 2024 | -$4,395.60 | — | $10.1K | — | 10-Q |
| Mar 28, 2024 | Q4 2023 | -$599.40 | — | $13.8KEst: $14.0K | -1.5% | 10-K |
| Nov 14, 2023 | Q3 2023 | -$19,180.80 | — | $19.1KEst: $70.0K | -72.8% | — |
| Aug 25, 2023 | Q2 2023 | -$28,771.20Est: -$14,385.60 | -100.0% | $17.1KEst: $50.0K | -65.9% | 10-Q |
| Jul 3, 2023 | Q1 2023 | -$23,976.00Est: $0.00 | — | $25.5KEst: $20.0K | +27.4% | 10-Q |
| Feb 27, 2023 | Q4 2022 | -$15,984.00Est: -$25,574.40 | +37.5% | $22.5KEst: $20.0K | +12.6% | — |